Desch, Steffen; Freund, Anne; Graf, Tobias; Fichtlscherer, Stephan; Haake, Hendrik; Preusch, Michael; Hammer, Fabian; Akin, Ibrahim; Christ, Martin; Liebetrau, Christoph; Skurk, Carsten; Steiner, Stephan; Voigt, Ingo; Schmitz, Roland; Mudra, Harald; Ledwoch, Jakob; Menck, Niels; Horstkotte, Jan; Pels, Klaus; Lahmann, Anna-Lena; Otto, Sylvia; Lenk, Karsten; Ohlow, Marc-Alexander; Hassager, Christian; Nordbeck, Peter; Zeymer, Uwe; Jobs, Alexander; de Waha-Thiele, Suzanne; Olbrich, Denise; Koenig, Inke; Klinge, Kathrin; Thiele, Holger     «

Desch, Steffen; Freund, Anne; Graf, Tobias; Fichtlscherer, Stephan; Haake, Hendrik; Preusch, Michael; Hammer, Fabian; Akin, Ibrahim; Christ, Martin; Liebetrau, Christoph; Skurk, Carsten; Steiner, Stephan; Voigt, Ingo; Schmitz, Roland; Mudra, Harald; Ledwoch, Jakob; Menck, Niels; Horstkotte, Jan; Pels, Klaus; Lahmann, Anna-Lena; Otto, Sylvia; Lenk, Karsten; Ohlow, Marc-Alexander; Hassager, Christian; Nordbeck, Peter; Zeymer, Uwe; Jobs, Alexander; de Waha-Thiele, Suzanne; Olbrich, Denise; Koenig,...     »

Background Patients experiencing out-of-hospital cardiac arrest (OHCA) without ST-segment elevation are a heterogenic group with a variety of underlying causes. Up to one-third of patients display a significant coronary lesion compatible with myocardial infarction as OHCA trigger. There are no randomized data on patient selection and timing of invasive coronary angiography after admission. Methods and results The TOMAHAWK trial randomly assigns 558 patients with return of spontaneous circulation after OHCA with no obvious extracardiac origin of cardiac arrest and no ST-segment elevation/left bundle-branch block on postresuscitation electrocardiogram to either immediate coronary angiography or initial intensive care assessment with delayed/selective angiography in a 1:1 ratio. The primary end point is 30-day all-cause mortality. Secondary analyses will be performed with respect to initial rhythm, electrocardiographic patterns, myocardial infarction as underlying cause, neurological outcome, as well as clinical and laboratory markers. Clinical follow-up will be performed at 6 and 12 months. Safety end points include bleeding and stroke. Conclusion The TOMAHAWK trial will address the unresolved issue of timing and general indication of angiography after OHCA without ST-segment elevation.     «

Background Patients experiencing out-of-hospital cardiac arrest (OHCA) without ST-segment elevation are a heterogenic group with a variety of underlying causes. Up to one-third of patients display a significant coronary lesion compatible with myocardial infarction as OHCA trigger. There are no randomized data on patient selection and timing of invasive coronary angiography after admission. Methods and results The TOMAHAWK trial randomly assigns 558 patients with return of spontaneous circulat...     »